41 Results for "

High-potency inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (41)

41 Results for "High-potency inhibitors" in MCE Product Catalog:

35
35 Publications Verification
Cat. No.: HY-13238
CAS No.: 1051375-16-6
Purity:  99.85%
Synonyms: S/GSK1349572
Target:  

HIV Integrase HIV

Research Areas:  

Infection

Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM) .
loading...
    loading...
35
35 Publications Verification
Cat. No.: HY-13238A
CAS No.: 1051375-19-9
Purity:  99.97%
Synonyms: S/GSK1349572 sodium
Target:  

HIV Integrase HIV

Research Areas:  

Infection

Dolutegravir sodium (S/GSK1349572 sodium) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir sodium (S/GSK1349572 sodium) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir sodium (S/GSK1349572 sodium) retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-133129
CAS No.: 2225938-17-8
Purity:  98.92%
MS1943 is an orally active selective HyT degrader of EZH2 that effectively reduces EZH2 levels in cells. MS1943 has anticancer activity and exhibits cytotoxic effects in a variety of TNBC cells while sparing normal cells. In addition, MS1943 maintains high potency (IC50=120 nM) in inhibiting EZH2 methyltransferase activity and is highly selective for EZH2. (Structure Note: RED, EZH2 ligand (HY-148458); Blue, Hyt (HY-W001578)) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107390
CAS No.: 1370544-73-2
Purity:  99.29%
AX-024 is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 modulates cell signaling by targeting SH3 domains. AX-024 has low-acute toxicity and high potency and selectivity, and strongly inhibit the production of IL-6, TNF-α, IFN-γ, IL-10 and IL-17A.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107390A
CAS No.: 1704801-24-0
Purity:  99.75%
AX-024 hydrochloride is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 hydrochloride modulates cell signaling by targeting SH3 domains. AX-024 hydrochloride has low-acute toxicity and high potency and selectivity, and strongly inhibit the production of IL-6, TNF-α, IFN-γ, IL-10 and IL-17A.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-151136
CAS No.: 1105110-83-5
Purity:  99.32%
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

DY-46-2 is a high potency and selectivity novel non-nucleoside DNA methyltransferase 3A (DNMT3A) inhibitor with an IC50 value of 0.39 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-150617
CAS No.: 2495096-26-7
Purity:  99.94%
Synonyms: M4076; ATM Inhibitor-5
Lartesertib (M4076) is an inhibitor of the serine/threonine protein kinase ATM with high potency. Lartesertib can inhibit the growth of multiple hematopoietic cell lines. Additionally, when combined with the ATR inhibitor Tuvusertib (HY-111451), Lartesertib can promote the death of tumor cells, activate the immune signaling pathway, and exhibit anti-tumor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109189
CAS No.: 1835667-12-3
Purity:  99.62%
Synonyms: BPI-7711
Target:  

EGFR

Research Areas:  

Cancer

Rezivertinib (BPI-7711) is an orally active, highly selective and irreversible third-generation EGFR tyrosine kinase inhibitor (TKI). Rezivertinib exhibits high potency against the common activation EGFR and the resistance T790M mutations. Rezivertinib has excellent central nervous system (CNS) penetration and has antitumor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12988
CAS No.: 192718-06-2
Purity:  99.88%
Target:  

Deubiquitinase

Research Areas:  

Cancer

C527 is a is a pan DUB enzyme inhibitor, with a high potency for the USP1/UAF1 complex (IC50=0.88 μM).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132889
CAS No.: 2766623-38-3
Purity:  98.31%
Target:  

SWI/SNF Complex

Research Areas:  

Others

BPTF-IN-BZ1, a BPTF inhibitor, possesses a high potency (Kd = 6.3 nM).
loading...
    loading...
Cat. No.: HY-D0004
CAS No.: 531-55-5
Synonyms: Azure B chloride
Azure B is a cationic dye and the major metabolite of Methylene blue. Azure B is used in making Azure eosin stains for blood smear staining. Azure B is a high-potency, selective and reversible inhibitor of monoamine oxidases (MAO)-A, with IC50s of 11 and 968 nM for recombinant human MAO-A and MAO-B, respectively. Azure B possesses significant antidepressant-like effects .
loading...
    loading...
Cat. No.: HY-19985
CAS No.: 1428774-45-1
Target:  

EGFR

Research Areas:  

Cancer

PF-06459988 is an orally activity, irreversible and mutant-selective inhibitor of EGFR mutant forms. PF-06459988 demonstrates high potency and specificity to the T790M-containing double mutant EGFRs. PF-06459988 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-105099
CAS No.: 129791-92-0
Purity:  99.64%
Synonyms: KRM-1648; ABI-1648
Rifalazil (KRM-1648; ABI-1648), a rifamycin derivative, inhibits the bacterial DNA-dependent RNA polymerase and kills bacterial cells by blocking off the β-subunit in RNA polymerase . Rifalazil (KRM-1648; ABI-1648) is an antibiotic, exhibits high potency against mycobacteria, gram-positive bacteria, Helicobacter pylori, C. pneumoniae and C. trachomatis with MIC values from 0.00025 to 0.0025 μg/ml . Rifalazil (KRM-1648; ABI-1648) has the potential for the treatment of Chlamydia infection, Clostridium difficile associated diarrhea (CDAD), and tuberculosis (TB) .
loading...
    loading...
Cat. No.: HY-120210
CAS No.: 1873358-87-2
Purity:  99.68%
Target:  

ROR

Research Areas:  

Inflammation/Immunology Cancer

XY018 is a potent ROR-γ-selective antagonist. XY018 inhibits ROR-γ constitutive activity in 293T cells with high potency (EC50, 190 nM). XY018 binds to the ROR-γ hydrophobic ligand binding domain (LBD) .
loading...
    loading...
Cat. No.: HY-151367
CAS No.: 2494010-42-1
Purity:  98.63%
Target:  

ERK

Research Areas:  

Cancer

SHR2415 is a highly potent, selective and orally active ERK1/2 inhibitor. SHR2415 has inhibition activity for ERK1 and ERK2 with IC50 values of 2.8 nM and 5.9 nM, respectively. SHR2415 exhibits high potency with an IC50 value of 44.6 nM in Colo205 cells. SHR2415 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-106481
CAS No.: 54867-56-0
Purity:  95.16%
Research Areas:  

Inflammation/Immunology

Bufrolin is a Cromoglycate (histamine release inhibitor) analog and a high potency agonist of GPR35. Bufrolin promotes interactions between β-arrestin-2 and either human GPR35a or rat GPR35. Bufrolin also serves as antiallergic mast cell stabilizer and inhibit an anti-inflammatory response inducible by the internalization peptide. Bufrolin acts as an anti-inflammatory agent to be used in research of delivering pharmacol linked with internalization peptide .
loading...
    loading...
Cat. No.: HY-D0004R
CAS No.: 531-55-5
Synonyms: Azure B chloride (Standard)
Azure B (Standard) is the analytical standard of Azure B. This product is intended for research and analytical applications. Azure B is a cationic dye and the major metabolite of Methylene blue. Azure B is used in making Azure eosin stains for blood smear staining. Azure B is a high-potency, selective and reversible inhibitor of monoamine oxidases (MAO)-A, with IC50s of 11 and 968 nM for recombinant human MAO-A and MAO-B, respectively. Azure B possesses significant antidepressant-like effects .
loading...
    loading...
Cat. No.: HY-153612
CAS No.: 298217-59-1
Purity:  ≥95.0%
Target:  

GLUT Parasite

Research Areas:  

Infection Inflammation/Immunology

MMV009085 is a potent PfHT1 (Plasmodium falciparum hexose transporter)-specific inhibitor and a potential anti-malarial agent . MMV009085 is also a human glucose transporter inhibitor, it has high potency in inhibiting both glucose uptake (IC50: 2.6 μM in glucose uptake assay) and growth of the parasites (EC50: 1.23±0.04 μM against 3D7) .
loading...
    loading...
Cat. No.: HY-150617A
CAS No.: 2020089-41-0
Synonyms: (Rac)-M4076; (Rac)-ATM Inhibitor-5
(Rac)-Lartesertib ((Rac)-M4076) is an isoform of Lartesertib (HY-150617). Lartesertib (M4076) is an inhibitor of the serine/threonine protein kinase ATM with high potency. Lartesertib can inhibit the growth of multiple hematopoietic cell lines. Additionally, when combined with the ATR inhibitor Tuvusertib (HY-111451), Lartesertib can promote the death of tumor cells, activate the immune signaling pathway, and exhibit anti-tumor activity .
loading...
    loading...
Cat. No.: HY-175260
CAS No.: 2136606-87-4
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

ZN-c5 is a selective and orally active estrogen receptor degrader. ZN-c5 exhibits high potency in the cellular assay (MCF-7, IC50 = 0.3 nM) and binds with high affinity to ERα and ERβ (IC50 = 0.4 nM and 0.8 nM, respectively). ZN-c5 inhibits tumor growth in MCF-7 mouse xenograft model and WHIM20 xenograft model. ZN-c5 can be used for the study of breast cancer .
loading...
    loading...